Healthcare costs related to adverse events in hepatocellular carcinoma treatment: A retrospective observational claims study.
Lincy S LalAbdalla AlyLisa B LeSusan PeckousBrian SealApril TeitelbaumPublished in: Cancer reports (Hoboken, N.J.) (2021)
This real-world study demonstrated AE burden in alignment with previous clinical studies. Regardless of regimen used, AEs are associated with substantial healthcare costs due to inpatient care.